Podiatrist, Foot & Ankle Surgery · Deer Park, TX
NPI
1013959477
Since 2006
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
112 W Pasadena Blvd
Deer Park, TX, 77536
Phone (281) 479-5311
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
961 services
Medicare patients, 2024
219
Average age 74
Drug cost, 2024
$592K
690 prescriptions
Company payments, 2025
$26K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daren M Guertin was code 11721 (nail procedure), 222 times for 86 patients. In total Daren M Guertin billed 961 services in 61 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 11721 Nail Procedure | Office | 222 | 86 | $31.47 | $6,987 |
| 99213 Office E&M - Established | Office | 116 | 67 | $67.64 | $7,846 |
| 99203 Office E&M - New | Office | 96 | 96 | $76.46 | $7,340 |
| 11056 Removal or Shaving of Skin Growth | Office | 65 | 35 | $62.45 | $4,059 |
| 73630 X-ray - Lower Extremity | Office | 44 | 33 | $26.65 | $1,173 |
| 11750 Nail Procedure | Office | 31 | 25 | $124.92 | $3,872 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 15 | $64.40 | $1,803 |
| 99222 Hospital E&M - Initial | Facility | 26 | 24 | $107.29 | $2,789 |
| 97597 Debridement | Office | 24 | 12 | $81.17 | $1,948 |
| 11042 Debridement | Office | 24 | 12 | $83.66 | $2,008 |
| 11055 Removal or Shaving of Skin Growth | Office | 22 | 16 | $50.20 | $1,104 |
| 99204 Office E&M - New | Office | 13 | 13 | $130.71 | $1,699 |
| 99214 Office E&M - Established | Office | 12 | 11 | $105.37 | $1,264 |
By year: 2022 $59K for 768 services; 2023 $42K for 615 services; 2024 $68K for 961 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daren M Guertin prescribed most often to Medicare patients was Mupirocin, with 130 prescriptions and refills. In total Daren M Guertin wrote 690 Medicare prescriptions that cost $592K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 130 | 138 | 88 | $1,149 |
| Nuzyra Omadacycline Tosylate | 62 | 62 | 32 | $478K |
| Clotrimazole Generic | 53 | 57 | 29 | $890 |
| Ciclopirox Generic | 35 | 39 | 26 | $1,220 |
| Terbinafine Hcl Generic | 33 | 90 | 30 | $752 |
| Jublia Efinaconazole | 32 | 43 | 20 | $42K |
| Gabapentin Generic | 25 | 37 | 11 | $264 |
| Clindamycin Hcl Generic | 24 | 24 | 23 | $201 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 20 | 20 | 18 | $197 |
| Doxycycline Hyclate Generic | 18 | 18 | 17 | $234 |
| Fluconazole Generic | 18 | 18 | 11 | $232 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 | 18 | 18 | $148 |
| Ciprofloxacin Hcl Generic | 16 | 16 | 14 | $257 |
| Levofloxacin Generic | 16 | 16 | Under 11 | $55.13 |
| Linezolid Generic | 15 | 15 | 11 | $2,020 |
Brand drugs: 125 claims; generic drugs: 565 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daren M Guertin $26K ($26K in general payments such as food, travel and fees) from 12 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 54 | $19K |
| Kerecis Limited | 8 | $6,427 |
| Paragon 28, Inc. ZBH | 2 | $188 |
| Linvatec Corporation CNMD | 1 | $165 |
| Amgen Inc. AMGN | 1 | $117 |
| MIMEDX Group, Inc. MDXG | 3 | $59.67 |
| Smith+Nephew, Inc. SNN | 1 | $57.01 |
| Stryker Corporation SYK | 1 | $49.48 |
| Treace Medical Concepts, Inc. TMCI | 2 | $41.91 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $23.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.